BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esposito JG, Thomas SG, Kingdon L, Ezzat S. Anabolic growth hormone action improves submaximal measures of physical performance in patients with HIV-associated wasting. Am J Physiol Endocrinol Metab 2005;289:E494-503. [PMID: 15886228 DOI: 10.1152/ajpendo.00013.2005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.1] [Reference Citation Analysis]
Number Citing Articles
1 Stanley TL, Grinspoon SK. GH/GHRH axis in HIV lipodystrophy. Pituitary 2009;12:143-52. [DOI: 10.1007/s11102-008-0092-8] [Cited by in Crossref: 30] [Cited by in F6Publishing: 26] [Article Influence: 2.1] [Reference Citation Analysis]
2 Graham MR, Baker JS, Evans P, Hullin D, Thomas NE, Davies B. Potential benefits of recombinant human growth hormone (rhGH) to athletes. Growth Horm IGF Res 2009;19:300-7. [PMID: 19539505 DOI: 10.1016/j.ghir.2009.04.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
3 Curtis VA, Allen DB. Boosting The Late Blooming Male: Use of growth promoting agents in the athlete with constitutional delay of growth and puberty. Sports Health 2011;3:32-40. [PMID: 21691451 DOI: 10.1177/1941738110386705] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Graham MR, Baker JS, Evans P, Kicman A, Cowan D, Hullin D, Thomas N, Davies B. Physical Effects of Short-Term Recombinant Human Growth Hormone Administration in Abstinent Steroid Dependency. Horm Res Paediatr 2008;69:343-54. [DOI: 10.1159/000117390] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
5 Mendias CL, Enselman ERS, Olszewski AM, Gumucio JP, Edon DL, Konnaris MA, Carpenter JE, Awan TM, Jacobson JA, Gagnier JJ, Barkan AL, Bedi A. The Use of Recombinant Human Growth Hormone to Protect Against Muscle Weakness in Patients Undergoing Anterior Cruciate Ligament Reconstruction: A Pilot, Randomized Placebo-Controlled Trial. Am J Sports Med 2020;48:1916-28. [PMID: 32452208 DOI: 10.1177/0363546520920591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Badowski M, Pandit NS. Pharmacologic management of human immunodeficiency virus wasting syndrome. Pharmacotherapy 2014;34:868-81. [PMID: 24782295 DOI: 10.1002/phar.1431] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
7 Wetzel JL, Fry DK, Pfalzer LA. Six-minute walk test for persons with mild or moderate disability from multiple sclerosis: performance and explanatory factors. Physiother Can 2011;63:166-80. [PMID: 22379256 DOI: 10.3138/ptc.2009-62] [Cited by in Crossref: 39] [Cited by in F6Publishing: 34] [Article Influence: 3.5] [Reference Citation Analysis]
8 Clemmons DR, Miller S, Mamputu JC. Safety and metabolic effects of tesamorelin, a growth hormone-releasing factor analogue, in patients with type 2 diabetes: A randomized, placebo-controlled trial. PLoS One 2017;12:e0179538. [PMID: 28617838 DOI: 10.1371/journal.pone.0179538] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
9 Steinman J, DeBoer MD. Treatment of cachexia: melanocortin and ghrelin interventions. Vitam Horm 2013;92:197-242. [PMID: 23601426 DOI: 10.1016/B978-0-12-410473-0.00008-8] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
10 Esposito JG, Thomas SG, Kingdon L, Ezzat S. Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormone. J Clin Endocrinol Metab 2006;91:2952-9. [PMID: 16757527 DOI: 10.1210/jc.2006-0431] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
11 Jong E, Oudhoff LA, Epskamp C, Wagener MN, van Duijn M, Fischer S, van Gorp EC. Predictors and treatment strategies of HIV-related fatigue in the combined antiretroviral therapy era. AIDS 2010;24:1387-405. [DOI: 10.1097/qad.0b013e328339d004] [Cited by in Crossref: 71] [Cited by in F6Publishing: 32] [Article Influence: 5.9] [Reference Citation Analysis]
12 Sigalos JT, Pastuszak AW. The Safety and Efficacy of Growth Hormone Secretagogues. Sex Med Rev 2018;6:45-53. [PMID: 28400207 DOI: 10.1016/j.sxmr.2017.02.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
13 Oursler KK, Katzel LI, Smith BA, Scott WB, Russ DW, Sorkin JD. Prediction of cardiorespiratory fitness in older men infected with the human immunodeficiency virus: clinical factors and value of the six-minute walk distance. J Am Geriatr Soc 2009;57:2055-61. [PMID: 19793156 DOI: 10.1111/j.1532-5415.2009.02495.x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.2] [Reference Citation Analysis]
14 Chetta A, Zanini A, Pisi G, Aiello M, Tzani P, Neri M, Olivieri D. Reference values for the 6-min walk test in healthy subjects 20-50 years old. Respir Med 2006;100:1573-8. [PMID: 16466676 DOI: 10.1016/j.rmed.2006.01.001] [Cited by in Crossref: 160] [Cited by in F6Publishing: 144] [Article Influence: 10.0] [Reference Citation Analysis]
15 Mbada CE, Onayemi O, Ogunmoyole Y, Johnson OE, Akosile CO. Health-related quality of life and physical functioning in people living with HIV/AIDS: a case-control design. Health Qual Life Outcomes 2013;11:106. [PMID: 23802924 DOI: 10.1186/1477-7525-11-106] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
16 Apor P, Tihanyi J, Costa A. [Increase of muscle mass and strength with hormones and other drugs, combined with physical training]. Orv Hetil 2007;148:451-6. [PMID: 17350911 DOI: 10.1556/OH.2007.27793] [Reference Citation Analysis]
17 Gullett NP, Hebbar G, Ziegler TR. Update on clinical trials of growth factors and anabolic steroids in cachexia and wasting. Am J Clin Nutr. 2010;91:1143S-1147S. [PMID: 20164318 DOI: 10.3945/ajcn.2010.28608e] [Cited by in Crossref: 63] [Cited by in F6Publishing: 25] [Article Influence: 5.3] [Reference Citation Analysis]